logo
logo

Terrana Biosciences raised $50M in a Series A funding from Flagship Pioneering to scale operations and develop its RNA-based agricultural solutions.

Jul 03, 2025•13 days ago

Amount Raised

$50 Million

Round Type

series a

CambridgeBiotechnology

Investors

Flagship Pioneering

Description

Terrana Biosciences, a Cambridge, MA-based company providing RNA-based agricultural solutions, received $50M from Flagship Pioneering. The company intends to use the funds to scale operations and develop its first products in crop protection and yield. Led by co-CEOs Noubar Afeyan and Ryan Rapp, Terrana combines RNA technology with advanced computational biology. They have created a pipeline of 15+ potential products in specialty and row crops.

Company Information

Company

Terrana Biosciences

Location

Cambridge, Massachusetts, United States

About

Terrana’s novel technology platform enables resilient agriculture for a rapidly changing world through RNA-based plant health solutions. Our technology opens the door to endowing crops with any desired trait without altering the plant genome and delivering solutions with unmatched flexibility, precision, and speed that can be applied at any point in a plant’s lifecycle.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People